900196586	900196586	CD	B-NP	O
|	|	NN	I-NP	O
SMH	SMH	NN	I-NP	O
|	|	NN	I-NP	O
30612183	30612183	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
5895550	5895550	CD	B-NP	O
|	|	CC	I-NP	O
10/6/2003	10/6/2003	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
chf	chf	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/6/2003	10/6/2003	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/2/2003	2/2/2003	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
BERLINSKI	BERLINSKI	NNP	B-NP	O
,	,	,	O	O
ROLAND	ROLAND	NNP	B-NP	O
C.	C.	NNP	I-NP	O
203-05-33-5	203-05-33-5	CD	I-NP	O
Bomerille	Bomerille	NNP	I-NP	O
I	I	NNP	I-NP	O
Tall	Tall	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
8/24/03	8/24/03	CD	B-NP	O
AT	AT	NN	I-NP	O
03	03	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
HOLIEN	HOLIEN	NNP	B-NP	O
,	,	,	O	O
TEDDY	TEDDY	NNP	B-NP	O
DONNELL	DONNELL	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
VITAMIN	VITAMIN	NNP	B-NP	O
C	C	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ASCORBIC	ASCORBIC	NNP	I-NP	O
ACID	ACID	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
PROPINE	PROPINE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DIPIVEFRIN	DIPIVEFRIN	NNP	I-NP	O
0.1	0.1	CD	B-NP	O
%	%	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
DROP	DROP	NN	I-NP	O
OU	OU	NN	I-NP	O
BID	BID	NN	I-NP	O
FOLIC	FOLIC	NN	I-NP	O
ACID	ACID	NN	I-NP	O
1	1	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
LENTE	LENTE	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
LENTE	LENTE	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
SYNTHROID	SYNTHROID	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
200	200	CD	I-NP	O
MCG	MCG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
ZAROXOLYN	ZAROXOLYN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METOLAZONE	METOLAZONE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
5	5	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QAM	QAM	NN	I-NP	O
OXYCODONE	OXYCODONE	NN	I-NP	O
5	5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q6H	Q6H	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
3/16/03	3/16/03	CD	B-NP	O
by	by	IN	B-PP	O
JUKES	JUKES	NNP	B-NP	O
,	,	,	O	O
BRICE	BRICE	NNP	B-NP	O
NORMAN	NORMAN	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
DEFINITE	DEFINITE	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OR	OR	NNP	I-NP	O
SENSITIVITY	SENSITIVITY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
to	to	TO	B-PP	O
NARCOTICS	NARCOTICS	NNP	B-NP	O
,	,	,	O	O
PHENANTHRENES	PHENANTHRENES	NNP	B-NP	O
POSSIBLE	POSSIBLE	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OR	OR	NNP	I-NP	O
SENSITIVITY	SENSITIVITY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
to	to	TO	B-PP	O
NARCOTICS	NARCOTICS	NNP	B-NP	O
,	,	,	O	O
PHENANTHRENES	PHENANTHRENES	NNP	B-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	B-DNA
aware	aware	JJ	I-NP	I-DNA
VITAMIN	VITAMIN	NN	I-NP	I-DNA
B	B	NN	I-NP	I-DNA
6	6	CD	I-NP	I-DNA
-LRB-	-LRB-	NN	I-NP	I-DNA
PYRIDOXINE	PYRIDOXINE	NN	I-NP	I-DNA
HCL	HCL	NN	I-NP	I-DNA
-RRB-	-RRB-	NN	I-NP	I-DNA
50	50	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
QD	QD	NNP	I-NP	I-DNA
VITAMIN	VITAMIN	NNP	I-NP	I-DNA
E	E	NNP	I-NP	I-DNA
-LRB-	-LRB-	NNP	I-NP	I-DNA
TOCOPHEROL-DL-ALPHA	TOCOPHEROL-DL-ALPHA	NNP	I-NP	I-DNA
-RRB-	-RRB-	NNP	I-NP	I-DNA
400	400	CD	I-NP	I-DNA
UNITS	UNITS	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
MULTIVITAMIN	MULTIVITAMIN	NNP	I-NP	O
THERAPEUTIC	THERAPEUTIC	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
THERAPEUTIC	THERAPEUTIC	NNP	I-NP	O
MULTIVI	MULTIVI	NNP	I-NP	O
...	...	:	O	O
-RRB-	-RRB-	SYM	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	B-protein
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
9/15/03	9/15/03	CD	B-NP	O
by	by	IN	B-PP	O
COURSE	COURSE	NN	B-NP	O
,	,	,	O	O
TUAN	TUAN	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
ZOCOR	ZOCOR	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
69826847	69826847	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
NIACIN	NIACIN	NN	B-NP	B-protein
,	,	,	O	O
VIT	VIT	NN	B-NP	B-protein
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
&	&	CC	I-NP	O
SIMVASTATIN	SIMVASTATIN	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
HUMULIN	HUMULIN	NN	I-NP	O
70/30	70/30	CD	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
70/30	70/30	CD	I-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
HUMAN	HUMAN	NN	I-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
70	70	CD	I-NP	I-protein
UNITS	UNITS	NNP	I-NP	I-protein
SC	SC	NNP	I-NP	I-protein
QAM	QAM	NNP	I-NP	I-protein
NEURONTIN	NEURONTIN	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
GABAPENTIN	GABAPENTIN	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	O
300	300	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
TID	TID	NN	I-NP	O
TORSEMIDE	TORSEMIDE	NN	I-NP	O
100	100	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
TRUSOPT	TRUSOPT	NN	I-NP	O
-LRB-	-LRB-	SYM	O	O
DORZOLAMIDE	DORZOLAMIDE	NN	B-NP	O
2	2	CD	I-NP	O
%	%	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
1	1	CD	I-NP	O
DROP	DROP	NNP	I-NP	O
OU	OU	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
FLONASE	FLONASE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FLUTICASONE	FLUTICASONE	NNP	I-NP	O
NASAL	NASAL	NNP	I-NP	O
SPRAY	SPRAY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
1-2	1-2	NN	I-NP	O
SPRAY	SPRAY	NNP	I-NP	O
INH	INH	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
10	10	CD	B-NP	O
XALATAN	XALATAN	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
LATANOPROST	LATANOPROST	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
1	1	CD	I-NP	O
DROP	DROP	NNP	I-NP	O
OU	OU	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
10	10	CD	B-NP	O
ADVAIR	ADVAIR	NN	I-NP	O
DISKUS	DISKUS	IN	B-PP	O
100/50	100/50	CD	B-NP	O
-LRB-	-LRB-	SYM	I-NP	O
FLUTICASONE	FLUTICASONE	NN	I-NP	O
PROPIONATE	PROPIONATE	NN	I-NP	O
/	/	SYM	B-NP	O
...	...	:	O	B-protein
-RRB-	-RRB-	SYM	B-NP	I-protein
1	1	CD	I-NP	I-protein
PUFF	PUFF	NN	I-NP	I-protein
INH	INH	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
3/16/03	3/16/03	CD	B-NP	O
by	by	IN	B-PP	O
VAULX	VAULX	NNP	B-NP	O
,	,	,	O	O
FREDRIC	FREDRIC	NNP	B-NP	O
HAI	HAI	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LEVAQUIN	LEVAQUIN	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
08221087	08221087	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SALMETEROL	SALMETEROL	NNP	B-NP	O
XINAFOATE	XINAFOATE	NNP	I-NP	O
&	&	CC	I-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
3/16/03	3/16/03	CD	B-NP	O
by	by	IN	B-PP	O
COLLINGWOOD	COLLINGWOOD	NN	B-NP	O
,	,	,	O	O
ELOY	ELOY	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LEVOFLOXACIN	LEVOFLOXACIN	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
31805771	31805771	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SALMETEROL	SALMETEROL	NNP	B-NP	O
XINAFOATE	XINAFOATE	NNP	I-NP	O
&	&	CC	I-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
EKG	EKG	NNP	B-NP	B-protein
PRILOSEC	PRILOSEC	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
OMEPRAZOLE	OMEPRAZOLE	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
20	20	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
ALBUTEROL	ALBUTEROL	NN	I-NP	I-protein
INHALER	INHALER	NN	I-NP	I-protein
HFA	HFA	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
PUFF	PUFF	NN	I-NP	I-protein
INH	INH	NN	I-NP	I-protein
Q4-6H	Q4-6H	NN	I-NP	I-protein
PRN	PRN	NNP	I-NP	I-protein
Wheezing	Wheezing	NNP	I-NP	I-protein
REGULAR	REGULAR	NNP	I-NP	I-protein
INSULIN	INSULIN	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
REGULAR	REGULAR	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
54	54	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
TAMOXIFEN	TAMOXIFEN	NN	I-NP	O
20	20	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
hs	h	NNS	I-NP	O
B12	B12	NN	I-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	O
CYANOCOBALAMIN	CYANOCOBALAMIN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
MCG	MCG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
REGULAR	REGULAR	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
REGULAR	REGULAR	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2-50	2-50	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
per	per	IN	B-PP	O
dikin	dikin	NN	B-NP	O
alrid	alrid	JJ	B-NP	O
health	health	NN	I-NP	O
diabetes	diabetes	NN	I-NP	O
scale	scale	NN	I-NP	O
KCL	KCL	NN	I-NP	O
SLOW	SLOW	NN	I-NP	O
RELEASE	RELEASE	NN	I-NP	O
20	20	CD	I-NP	O
MEQ	MEQ	NN	I-NP	O
X	X	SYM	B-NP	O
2	2	CD	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
As	As	IN	B-PP	O
per	per	IN	B-PP	O
DMH	DMH	NN	B-NP	O
Potassium	Potassium	NN	I-NP	O
Chloride	Chloride	NN	I-NP	O
Policy	Policy	NN	I-NP	O
:	:	:	O	O
each	each	DT	B-NP	O
20	20	CD	I-NP	O
mEq	mEq	NN	I-NP	O
dose	dose	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
given	give	VBN	I-VP	O
with	with	IN	B-PP	O
4	4	CD	B-NP	O
oz	oz	NN	I-NP	O
of	of	IN	B-PP	O
fluid	fluid	NN	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
should	should	MD	B-VP	O
measure	measure	VB	I-VP	O
weight	weight	NN	B-NP	O
daily	daily	JJ	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
Fluid	Fluid	NN	B-NP	O
restriction	restriction	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
2100	2100	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Dudley	Dudley	NNP	I-NP	O
Vassar	Vassar	NNP	I-NP	O
3/3/03	3/3/03	CD	I-NP	O
at	at	IN	B-PP	O
11	11	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
am	am	NN	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Oleskiewicz	Oleskiewicz	NNP	I-NP	O
2/1/03	2/1/03	CD	I-NP	O
at	at	IN	B-PP	O
15	15	CD	B-NP	O
:	:	SYM	I-NP	O
40	40	CD	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
ALLERGY	ALLERGY	NNP	B-NP	O
:	:	:	O	O
Penicillins	Penicillins	NNP	B-NP	O
,	,	,	O	O
Demerol	Demerol	NNP	B-NP	O
,	,	,	O	O
Macrodantin	Macrodantin	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
nitrofurantoin	nitrofurantoin	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
chf	chf	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
chf	chf	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
chf	chf	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
dm	dm	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
urinary	urinary	JJ	I-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
urinary	urinary	JJ	I-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
71F	71F	NN	B-NP	O
with	with	IN	B-PP	O
extensive	extensive	JJ	B-NP	O
PMHs	PMH	NNS	I-NP	O
including	include	VBG	B-PP	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
diastolic	diastolic	JJ	B-NP	B-protein
dysfxn	dysfxn	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
EF	EF	NN	I-NP	I-protein
60	60	CD	B-NP	I-protein
%	%	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
AS	AS	NN	B-NP	O
,	,	,	O	O
AFib	AFib	NN	B-NP	O
,	,	,	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
CRI	CRI	NN	B-NP	B-protein
,	,	,	O	O
OSA	OSA	NN	B-NP	O
p/w	p/w	NN	I-NP	O
progressive	progressive	JJ	I-NP	O
dyspnea	dyspnea	NN	I-NP	O
,	,	,	O	O
fatigue	fatigue	NN	B-NP	O
,	,	,	O	O
periph	periph	NN	B-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
weight	weight	NN	B-NP	O
gain	gain	NN	I-NP	O
.	.	.	O	O

Admitted	Admit	VBN	B-NP	O
3wks	3wk	NNS	I-NP	O
ago	ago	IN	B-PP	O
w/similar	w/similar	JJ	B-NP	O
complaints	complaint	NNS	I-NP	O
-	-	HYPH	B-NP	O
was	be	VBD	B-VP	O
diuresed	diurese	VBN	I-VP	O
heavily	heavily	RB	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	I-NP	O
~	~	NN	I-NP	O
8lb	8lb	NN	I-NP	O
weight	weight	NN	I-NP	O
loss	loss	NN	I-NP	O
and	and	CC	O	O
symptomatic	symptomatic	JJ	B-NP	O
relief	relief	NN	I-NP	O
.	.	.	O	O

Post	Post	NNP	B-NP	O
D/C	D/C	NNP	I-NP	O
,	,	,	O	O
did	do	VBD	B-VP	O
well	well	RB	B-ADVP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
few	few	JJ	I-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
started	start	VBD	B-VP	O
developing	develop	VBG	I-VP	O
progressive	progressive	JJ	B-NP	O
DOE	DOE	NN	I-NP	O
,	,	,	O	O
fatigue	fatigue	NN	B-NP	O
,	,	,	O	O
orthopnea	orthopnea	NN	B-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
weight	weight	NN	B-NP	O
gain	gain	NN	I-NP	O
of	of	IN	B-PP	O
~	~	NN	B-NP	B-protein
8-10lbs	8-10lb	NNS	I-NP	I-protein
.	.	.	O	O

On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
could	could	MD	B-VP	O
not	not	RB	I-VP	O
walk	walk	VB	I-VP	O
more	more	JJR	B-NP	O
than	than	IN	B-SBAR	O
few	few	JJ	B-NP	O
feet	foot	NNS	I-NP	O
w/o	w/o	NN	I-NP	O
SOB	SOB	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
claimed	claim	VBD	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
compliant	compliant	JJ	B-ADJP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
and	and	CC	O	O
practiced	practiced	JJ	B-NP	O
dietary	dietary	JJ	I-NP	O
discretion	discretion	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
day	day	NN	B-NP	O
of	of	IN	B-PP	O
present	present	JJ	B-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
presented	present	VBD	B-VP	O
w/CHF	w/CHF	NN	B-NP	O
flare	flare	NN	I-NP	O
,	,	,	O	O
acute	acute	JJ	B-ADJP	O
on	on	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
RF	RF	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
ED	ED	NN	B-NP	O
,	,	,	O	O
BP	BP	NN	B-NP	O
87/45	87/45	CD	I-NP	O
,	,	,	O	O
P	P	NN	B-NP	B-protein
75	75	CD	I-NP	I-protein
,	,	,	I-NP	O
96	96	CD	I-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
,	,	,	O	O
afeb	afeb	NN	B-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
showed	show	VBD	B-VP	I-protein
AF	AF	NN	B-NP	I-protein
with	with	IN	B-PP	O
no	no	DT	B-NP	O
ST-T	ST-T	NN	I-NP	O
changes	change	NNS	I-NP	O
,	,	,	O	O
enz	enz	NN	B-NP	O
neg	neg	NN	I-NP	O
.	.	.	O	O

HCT	HCT	NN	B-NP	B-protein
30.7	30.7	CD	I-NP	I-protein
,	,	,	O	O
BUN	BUN	NN	B-NP	B-cell_line
105	105	CD	I-NP	I-cell_line
,	,	,	O	O
Cr	Cr	NNP	B-NP	O
2.4	2.4	CD	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
baseline	baseline	NN	I-NP	O
Cr	Cr	NN	I-NP	O
~	~	NN	I-NP	O
2.0	2.0	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
PE	PE	NN	I-NP	O
:	:	:	O	O
AOx3	AOx3	NN	B-NP	B-protein
,	,	,	O	O
resp	resp	NN	B-NP	O
distress	distress	NN	I-NP	O
,	,	,	O	O
JVP	JVP	NN	B-NP	B-protein
?	?	.	O	O

,	,	,	O	O
S1S2	S1S2	NN	B-NP	B-protein
,	,	,	O	O
3/6	3/6	CD	B-NP	O
AS	AS	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
,	,	,	O	O
trace	trace	NN	B-NP	O
rales	rale	NNS	I-NP	O
,	,	,	O	O
abd	abd	NN	B-NP	O
?	?	.	O	O

,	,	,	O	O
3	3	CD	B-NP	O
+	+	SYM	O	O
pitting	pit	VBG	B-VP	O
LE	LE	NN	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

Impression	Impression	NN	B-NP	O
:	:	:	O	O
71yo	71yo	CD	B-NP	O
woman	woman	NN	I-NP	O
w/CHF	w/CHF	NN	I-NP	O
,	,	,	O	O
AFib	AFib	NN	B-NP	O
,	,	,	O	O
AS	AS	NN	B-NP	O
,	,	,	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
CRI	CRI	NN	B-NP	B-protein
,	,	,	O	O
w/hx	w/hx	NN	B-NP	O
of	of	IN	B-PP	O
recent	recent	JJ	B-NP	O
CHF	CHF	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
now	now	RB	B-ADVP	O
p/w	p/w	VBP	B-VP	O
with	with	IN	B-PP	O
vol	vol	NN	B-NP	O
overload	overload	NN	I-NP	O
,	,	,	O	O
dyspnea	dyspnea	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
renal	renal	JJ	B-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

Etiology	Etiology	NN	B-NP	O
of	of	IN	B-PP	O
CHF	CHF	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
unclear	unclear	JJ	B-ADJP	O
:	:	:	O	O
she	she	PRP	B-NP	O
r/o	r/o	VBP	B-VP	O
for	for	IN	B-PP	O
MI	MI	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
worsening	worsening	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
afib	afib	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
si/sx	si/sx	NN	I-NP	O
's	's	POS	B-NP	O
of	of	IN	B-PP	O
infection	infection	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
hx	hx	NN	I-NP	O
to	to	TO	B-VP	O
suggest	suggest	VB	I-VP	O
dietary	dietary	JJ	B-NP	O
indiscretion	indiscretion	NN	I-NP	O
,	,	,	O	O
medical	medical	JJ	B-NP	O
non-compliance	non-compliance	NN	I-NP	O
,	,	,	O	O
lack	lack	NN	B-NP	O
of	of	IN	B-PP	O
medications	medication	NNS	B-NP	O
CV	CV	NN	I-NP	O
:	:	:	O	O
Isch	Isch	NNP	B-NP	O
-	-	:	O	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
:	:	:	O	O
pt	pt	JJ	B-NP	O
r/o	r/o	NN	I-NP	O
for	for	IN	B-PP	O
MI	MI	NN	B-NP	O
with	with	IN	B-PP	O
negative	negative	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
.	.	.	O	O

PUMP	PUMP	NN	B-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
gently	gently	RB	I-VP	O
diuresed	diurese	VBN	I-VP	O
~	~	NNP	B-NP	O
2L/day	2L/day	NNP	I-NP	O
on	on	IN	B-PP	O
Torsemide	Torsemide	NNP	B-NP	O
100	100	CD	I-NP	O
IV	IV	CD	I-NP	O
TID	TID	NN	I-NP	O
x	x	SYM	B-NP	O
4	4	CD	B-NP	O
days	day	NNS	I-NP	O
with	with	IN	B-PP	O
excellent	excellent	JJ	B-NP	O
response	response	NN	I-NP	O
and	and	CC	O	O
then	then	RB	B-ADVP	O
switched	switch	VBD	B-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
diuretic	diuretic	JJ	I-NP	O
regiment	regiment	NN	I-NP	O
of	of	IN	B-PP	O
100	100	CD	B-NP	O
mg	mg	NN	I-NP	O
BID	BID	NN	I-NP	O
of	of	IN	B-PP	O
PO	PO	NN	B-NP	O
torsemide	torsemide	NN	I-NP	O
and	and	CC	O	O
5	5	CD	B-NP	O
mg	mg	NN	I-NP	O
PO	PO	NN	I-NP	O
Zaroxolyn	Zaroxolyn	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
still	still	RB	B-ADVP	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
diuretic	diuretic	JJ	I-NP	O
effect	effect	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
admission	admission	NN	I-NP	O
wt	wt	NN	I-NP	O
was	be	VBD	B-VP	O
132.9	132.9	CD	B-NP	O
KG	KG	NN	I-NP	O
and	and	CC	B-PP	O
on	on	IN	B-PP	O
day	day	NN	B-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
she	she	PRP	B-NP	O
weighed	weigh	VBD	B-VP	O
125.8	125.8	CD	B-NP	O
kg	kg	NN	I-NP	O
:	:	:	O	O
net	net	JJ	B-NP	O
total	total	JJ	I-NP	O
loss	loss	NN	I-NP	O
of	of	IN	B-PP	O
7.1	7.1	CD	B-NP	O
kg	kg	NN	I-NP	O
or	or	CC	O	O
15.6	15.6	CD	B-NP	O
lbs	lb	NNS	I-NP	O
per	per	IN	B-PP	O
this	this	DT	B-NP	O
admit	admit	NN	I-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
strict	strict	JJ	B-NP	O
I/O	I/O	NNP	I-NP	O
's	's	POS	B-NP	O
,	,	,	O	O
daily	daily	JJ	B-NP	O
weight	weight	NN	I-NP	O
.	.	.	O	O

fluid	fluid	NN	B-NP	O
and	and	CC	I-NP	O
salt	salt	NN	I-NP	O
restriction	restriction	NN	I-NP	O
were	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
re-started	re-started	JJ	B-ADJP	O
on	on	IN	B-PP	O
Cozaar	Cozaar	NNP	B-NP	O
given	give	VBN	I-NP	O
BP	BP	NN	I-NP	O
's	's	POS	B-NP	O
in	in	IN	B-PP	O
low	low	JJ	B-NP	O
range	range	NN	I-NP	O
with	with	IN	B-PP	O
SBP	SBP	NN	B-NP	B-protein
:	:	:	O	O
90	90	CD	B-NP	O
;	;	:	O	O
s.	s.	NN	B-NP	O
RHYTHM	RHYTHM	NN	I-NP	O
:	:	:	O	O
chronic	chronic	JJ	B-NP	O
afib	afib	JJ	I-NP	O
w/good	w/good	JJ	I-NP	O
rate	rate	NN	I-NP	O
control	control	NN	I-NP	O
w/o	w/o	NN	I-NP	O
agent	agent	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
rate	rate	NN	I-NP	O
issues	issue	NNS	I-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
given	give	VBN	I-NP	O
hx	hx	NN	I-NP	O
of	of	IN	B-PP	O
GI	GI	NN	B-NP	O
bleed	bleed	NN	I-NP	O
.	.	.	O	O

Pulm	Pulm	NN	B-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
Advair	Advair	NN	I-NP	O
disk	disk	NN	I-NP	O
,	,	,	O	O
flonase	flonase	NN	B-NP	O
,	,	,	O	O
prn	prn	NN	B-NP	O
nebs	neb	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
CPAP	CPAP	NN	B-NP	B-protein
@	@	NN	I-NP	O
night	night	NN	I-NP	O
and	and	CC	O	O
did	do	VBD	B-VP	O
well	well	RB	B-ADVP	O
with	with	IN	B-PP	O
cpap	cpap	NN	B-NP	O
;	;	:	O	O
arrangements	arrangement	NNS	B-NP	O
were	be	VBD	B-VP	O
made	make	VBN	I-VP	O
for	for	IN	B-PP	O
pt	pt	NN	B-NP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
her	her	PRP$	B-NP	O
CPAP	CPAP	NN	I-NP	B-protein
at	at	IN	B-PP	O
home	home	NN	B-NP	O
changed	change	VBD	B-VP	O
to	to	TO	B-PP	O
hospital	hospital	NN	B-NP	O
setting	setting	NN	I-NP	O
and	and	CC	I-NP	O
equipment	equipment	NN	I-NP	O
.	.	.	O	O

HEME	HEME	NN	B-NP	B-protein
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
ANEMIA	ANEMIA	NN	I-NP	O
Pt	Pt	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
with	with	IN	B-PP	O
HCT	HCT	NN	B-NP	O
of	of	IN	B-PP	O
30.7	30.7	CD	B-NP	O
,	,	,	O	O
lower	low	JJR	B-ADJP	O
then	then	RB	B-ADVP	O
her	her	PRP$	B-NP	O
normal	normal	JJ	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
3	3	CD	B-NP	O
positive	positive	JJ	I-NP	O
stool	stool	NN	I-NP	O
guiaic	guiaic	NN	I-NP	O
's	's	POS	B-NP	O
,	,	,	O	O
low	low	JJ	B-NP	O
normal	normal	JJ	I-NP	O
Fe	Fe	NN	I-NP	O
studies	study	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
stable	stable	JJ	B-NP	O
HCT	HCT	NN	I-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
ASA	ASA	NN	I-NP	O
was	be	VBD	B-VP	O
stopped	stop	VBN	I-VP	O
2/2	2/2	CD	B-NP	O
concern	concern	NN	I-NP	O
for	for	IN	B-PP	O
GIB	GIB	NN	B-NP	B-protein
.	.	.	O	O

Pt	Pt	NN	B-NP	O
is	be	VBZ	B-VP	O
scheduled	schedule	VBN	I-VP	O
to	to	TO	I-VP	O
follow-up	follow-up	VB	I-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
GI	GI	NN	I-NP	O
doctor	doctor	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Ethan	Ethan	NNP	I-NP	O
Wasowski	Wasowski	NNP	I-NP	O
2	2	CD	I-NP	O
days	day	NNS	I-NP	O
after	after	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.2	.2	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
THROMBOCYTOPENIA	THROMBOCYTOPENIA	NN	I-NP	O
:	:	:	O	O
pt	pt	NN	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
drop	drop	NN	I-NP	O
in	in	IN	B-PP	O
platlets	platlet	NNS	B-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
concerning	concern	VBG	I-VP	O
,	,	,	O	O
but	but	CC	O	O
ultimately	ultimately	RB	B-VP	O
appeared	appear	VBD	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
lab	lab	JJ	B-NP	O
variation	variation	NN	I-NP	O
with	with	IN	B-PP	O
its	its	PRP$	B-NP	O
resolution	resolution	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
blood	blood	NN	I-NP	O
draw	draw	NN	I-NP	O
.	.	.	O	O

RENAL	RENAL	NN	B-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
with	with	IN	B-PP	O
acute	acute	JJ	B-ADJP	O
on	on	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
felt	feel	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
decreased	decrease	VBN	B-NP	O
CO.	CO.	NNP	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
CRT	CRT	NN	I-NP	O
elevation	elevation	NN	I-NP	O
gradually	gradually	RB	B-VP	O
resolved	resolve	VBN	I-VP	O
from	from	IN	B-PP	O
2.4	2.4	CD	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
to	to	TO	B-PP	O
1.8	1.8	CD	B-NP	O
at	at	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
celebrex	celebrex	NN	I-NP	O
was	be	VBD	B-VP	O
stopped	stop	VBN	I-VP	O
2/2	2/2	CD	B-NP	O
ARF	ARF	NN	I-NP	O
.	.	.	O	O

Proph	Proph	NN	B-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
Heparin	Heparin	NN	B-NP	O
5000u	5000u	CD	I-NP	O
SC	SC	NN	I-NP	O
BID	BID	NN	I-NP	O
for	for	IN	B-PP	O
DVT	DVT	NN	B-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
and	and	CC	O	O
Nexium	Nexium	NN	B-NP	O
40	40	CD	I-NP	O
GI	GI	NN	I-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
elevated	elevate	VBN	I-VP	O
LFT	LFT	NNP	B-NP	O
's	's	POS	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
labs	lab	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
peak	peak	NN	I-NP	O
LFT	LFT	NNP	B-NP	O
's	's	POS	B-NP	O
were	be	VBD	B-VP	O
ALT	ALT	NN	B-NP	O
:	:	:	O	O
368	368	CD	B-NP	O
,	,	,	O	O
AST	AST	NNP	B-NP	O
:	:	:	O	O
274	274	CD	B-NP	O
,	,	,	O	O
AP	AP	NN	B-NP	O
:	:	:	O	O
158	158	CD	B-NP	O
with	with	IN	B-PP	O
nl	nl	NN	B-NP	B-protein
BILIT	BILIT	NN	I-NP	I-protein
0.5	0.5	CD	I-NP	I-protein
and	and	CC	O	O
biliD	biliD	NN	B-NP	O
0.3	0.3	CD	I-NP	O
.	.	.	O	O

DDX	DDX	NN	B-NP	O
included	include	VBD	B-VP	O
congestion	congestion	NN	B-NP	O
vs	vs	IN	B-PP	O
infection	infection	NN	B-NP	O
vs	vs	IN	B-PP	O
medications	medication	NNS	B-NP	O
.	.	.	O	O

hepatitis	hepatitis	NN	B-NP	O
deemed	deem	VBD	B-VP	O
unlikely	unlikely	JJ	B-NP	O
but	but	CC	I-NP	O
hep	hep	JJ	I-NP	O
panel	panel	NN	I-NP	O
still	still	RB	B-ADVP	O
pending	pende	VBG	B-VP	O
at	at	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

Since	Since	IN	B-SBAR	O
pt	pt	NN	B-NP	O
's	's	POS	B-NP	O
LFT	LFT	NN	I-NP	O
's	's	POS	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
resolve	resolve	VB	I-VP	O
with	with	IN	B-PP	O
excellent	excellent	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
likely	likely	RB	B-ADJP	O
due	due	IN	B-PP	O
to	to	TO	I-PP	O
congestion	congestion	NN	B-NP	O
.	.	.	O	O

Most	Most	RBS	B-NP	O
likely	likely	JJ	I-NP	O
etiology	etiology	NN	I-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
reaction	reaction	NN	B-NP	O
to	to	TO	B-PP	O
drug	drug	NN	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
off	off	RP	B-PRT	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
hepatotoxic	hepatotoxic	JJ	I-NP	O
meds	med	NNS	I-NP	O
:	:	:	O	O
tylenol	tylenol	NN	B-NP	O
,	,	,	O	O
statin	statin	NN	B-NP	O
,	,	,	O	O
percocet	percocet	NN	B-NP	O
,	,	,	O	O
allopurinol	allopurinol	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
tamoxifen	tamoxifen	NN	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
case	case	NN	B-NP	O
reports	report	NNS	I-NP	O
of	of	IN	B-PP	O
hepatotoxicity	hepatotoxicity	NN	B-NP	O
noted	note	VBD	B-VP	O
;	;	:	O	O
other	other	JJ	B-NP	O
consideration	consideration	NN	I-NP	O
included	include	VBD	B-VP	O
the	the	DT	B-NP	O
neurontin	neurontin	NN	I-NP	B-protein
,	,	,	O	O
but	but	CC	O	O
lft	lft	NN	B-NP	O
's	's	POS	B-NP	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
normalize	normalize	VB	I-VP	O
on	on	IN	B-PP	O
medication	medication	NN	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
is	be	VBZ	B-VP	O
scheduled	schedule	VBN	I-VP	O
to	to	TO	I-VP	O
follow-up	follow-up	VB	I-VP	O
with	with	IN	B-PP	O
GI	GI	NNP	B-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Hornshaw	Hornshaw	NNP	I-NP	O
2	2	CD	B-NP	O
days	day	NNS	I-NP	O
following	follow	VBG	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

FEN	FEN	NN	B-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
's	's	POS	B-NP	O
lytes	lyte	NNS	I-NP	O
were	be	VBD	B-VP	O
aggressively	aggressively	RB	I-VP	O
repleted	replete	VBN	I-VP	O
;	;	:	O	O
she	she	PRP	B-NP	O
required	require	VBD	B-VP	O
significant	significant	JJ	B-NP	O
K	K	NN	I-NP	O
repletion	repletion	NN	I-NP	O
each	each	DT	B-NP	O
day	day	NN	I-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
d/c	d/c	NN	B-NP	O
'd	'd	MD	B-VP	O
on	on	IN	B-PP	O
K	K	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
NA	NA	NN	I-NP	O
and	and	CC	I-NP	O
fluid	fluid	NN	I-NP	O
restriction	restriction	NN	I-NP	O
and	and	CC	O	O
placed	place	VBN	B-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
and	and	CC	I-NP	O
diabetic	diabetic	JJ	I-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	NNP	B-NP	O
ENDO	ENDO	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
DM	DM	NN	B-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
RISS	RISS	NN	B-NP	B-protein
given	give	VBN	I-NP	O
concern	concern	NN	I-NP	O
for	for	IN	B-PP	O
hypogylcemia	hypogylcemia	NN	B-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
regiment	regiment	NN	I-NP	O
was	be	VBD	B-VP	O
gradually	gradually	RB	I-VP	O
added	add	VBN	I-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
inpatient	inpatient	JJ	I-NP	O
regiment	regiment	NN	I-NP	O
with	with	IN	B-PP	O
elevated	elevated	JJ	B-NP	O
FS	FS	NNP	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
at	at	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
sx	sx	NN	B-NP	O
's	's	POS	B-NP	O
much	much	JJ	I-NP	O
improved	improve	VBN	I-ADJP	O
,	,	,	O	O
and	and	CC	O	O
scheduled	scheduled	JJ	B-NP	O
f	f	NN	I-NP	O
or	or	CC	I-NP	O
follow-up	follow-up	NN	I-NP	O
with	with	IN	B-PP	O
cardiologist	cardiologist	NN	B-NP	O
and	and	CC	I-NP	O
CHF	CHF	NN	I-NP	O
nurse	nurse	NN	I-NP	O
on	on	IN	B-PP	O
8/28/03	8/28/03	CD	B-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
please	please	NN	I-NP	O
stop	stop	VB	B-VP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
medications	medication	NNS	I-NP	O
:	:	:	O	O
tylenol	tylenol	NN	B-NP	O
,	,	,	O	O
percocet	percocet	NN	B-NP	O
,	,	,	O	O
Zocor	Zocor	NN	B-NP	O
,	,	,	O	O
cozaar	cozaar	NN	B-NP	O
,	,	,	O	O
celebrex	celebrex	NN	B-NP	O
,	,	,	O	O
allopurinol	allopurinol	NN	B-NP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
2	2	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
follow-up	follow-up	NN	I-NP	O
on	on	IN	B-PP	O
your	your	PRP$	B-NP	O
liver	liver	NN	I-NP	O
enzyme	enzyme	NN	I-NP	O
elevations	elevation	NNS	I-NP	O
and	and	CC	O	O
guiaic	guiaic	JJ	B-NP	O
positive	positive	JJ	I-NP	O
stools	stool	NNS	I-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Kemfort	Kemfort	NNP	I-NP	O
3	3	CD	I-NP	O
-RRB-	-RRB-	HYPH	O	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
have	have	VBP	B-VP	O
any	any	DT	B-NP	O
worsening	worsen	VBG	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
fatigue	fatigue	NN	B-NP	O
,	,	,	O	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
swelling	swelling	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
any	any	DT	B-NP	O
concerning	concern	VBG	I-NP	O
symptoms	symptom	NNS	I-NP	O
,	,	,	O	O
please	please	VB	B-INTJ	O
call	call	VB	B-VP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
immediately	immediately	RB	B-ADVP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
follow-up	follow-up	NN	I-NP	O
for	for	IN	B-PP	O
LFT	LFT	NN	B-NP	O
elevations	elevation	NNS	I-NP	O
:	:	:	O	O
hepatitis	hepatitis	NN	B-NP	O
panel	panel	NN	I-NP	O
still	still	RB	B-VP	O
pending	pende	VBG	I-VP	O
at	at	IN	B-PP	O
d/c	d/c	NN	B-NP	O
2	2	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
follow-up	follow-up	NN	I-NP	O
for	for	IN	B-PP	O
guiaic	guiaic	JJ	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
+	+	SYM	B-VP	O
-RRB-	-RRB-	NN	B-NP	O
stool	stool	NN	I-NP	O
and	and	CC	O	O
Hct	Hct	NN	B-NP	O
drop	drop	NN	I-NP	O
3	3	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
The	The	DT	B-NP	O
following	follow	VBG	I-NP	O
medications	medication	NNS	I-NP	O
were	be	VBD	B-VP	O
stopped	stop	VBN	I-VP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
given	given	JJ	I-NP	O
concern	concern	NN	I-NP	O
re	re	NN	I-NP	O
:	:	:	O	O
elevated	elevate	VBN	B-VP	O
LFT	LFT	NNP	B-NP	O
's	's	POS	B-NP	O
,	,	,	O	O
ARF	ARF	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
guiaic	guiaic	JJ	B-NP	O
+	+	JJ	I-NP	O
stools	stool	NNS	I-NP	O
:	:	:	O	O
tylenol	tylenol	NN	B-NP	O
,	,	,	O	O
percocet	percocet	NN	B-NP	O
,	,	,	O	O
zocor	zocor	NN	B-NP	O
,	,	,	O	O
cozaar	cozaar	NN	B-NP	O
,	,	,	O	O
celebrex	celebrex	NN	B-NP	O
,	,	,	O	O
allopurinol	allopurinol	NN	B-NP	O
,	,	,	O	O
ASA	ASA	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
WOJNER	WOJNER	NNP	B-NP	O
,	,	,	O	O
ARMANDO	ARMANDO	NNP	B-NP	O
JARROD	JARROD	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DP22	DP22	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
8/24/03	8/24/03	CD	I-NP	O
@	@	SYM	B-NP	O
04	04	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

